United States Senate Special Committee on Aging
Hearings

Buyer Beware: Public Health Concerns of Counterfeit Medicine

July 9, 2002

 

This hearing will analyze the purchasing of pharmaceuticals - both brand name and generics - from outside the nation's borders and without the series of checks in place for drugs sold domestically.

    Date: July 9, 2001
    Time: 2:20 p.m.
    Dirksen 562

Statements of Committee Members

  •  

Witness Testimony


    Panel I

    1. Rick C. Roberts, San Francisco, California

    2. William K. Hubbard, Senior Associate for Policy, Planning and Legislation, Food and Drug Administration, Washington, DC

    3. Elizabeth G. Durant, Executive Director of Trade Programs, U.S. Customs Service, Washington, DC

    4. John Theriault, Vice President, Corporate Security, Pfizer, Inc., Washington, DC

Hearing Publications